Feasibility of switching anti-tumour necrosis factor-alpha therapy in patients with rheumatois arthritis

被引：0
|
作者：
Walsh, C. A. E. [1 ]
Minnock, P. [1 ]
Slattery, C. [1 ]
Kennedy, N. [1 ]
Veale, D. J. [1 ]
Bresnihan, B. [1 ]
FitzGerald, O. [1 ]
机构：
[1] St Vincents Univ Hosp, Dept Rheumatol, Dublin, Ireland
来源：
RHEUMATOLOGY | 2006年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：I52 / I52
页数：1
相关论文
共 50 条
  • [41] Long-term effects of anti-tumour necrosis factor therapy on weight in patients with rheumatoid arthritis
    Brown, Rachel A.
    Spina, Domenico
    Butt, Sayqa
    Summers, Gregory D.
    CLINICAL RHEUMATOLOGY, 2012, 31 (03) : 455 - 461
  • [42] Long-term effects of anti-tumour necrosis factor therapy on weight in patients with rheumatoid arthritis
    Rachel A. Brown
    Domenico Spina
    Sayqa Butt
    Gregory D. Summers
    Clinical Rheumatology, 2012, 31 : 455 - 461
  • [43] Anti-tumour necrosis factor therapy in seronegative spondyloarthritis
    Swales, C
    Bowness, P
    CLINICAL MEDICINE, 2005, 5 (03) : 219 - 222
  • [44] Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis
    Popa, C
    Netea, MG
    Radstake, T
    Van der Meer, JWM
    Stalenhoef, AFH
    van Riel, PLCM
    Barerra, P
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (02) : 303 - 305
  • [45] Effects of Adalimumab, an Anti-tumour Necrosis Factor-Alpha (TNF-alpha) Antibody, on Obese Diabetic Rats
    Shuwa, Halima Ali
    Dallatu, Muhammad Kabiru
    Yeldu, Muhammed Haruna
    Ahmed, Hamidu Marafa
    Nasir, Idris Abdullahi
    MALAYSIAN JOURNAL OF MEDICAL SCIENCES, 2018, 25 (04): : 51 - 62
  • [46] Combined tumour necrosis factor-alpha (TNF-alpha) and tumour necrosis factor receptor genotypes could predict rheumatoid arthritis patients' response to anti-TNF-alpha therapy and explain controversies
    Chatzikyriakidou, A.
    Georgiou, I.
    Voulgari, P. V.
    Venetsanopoulou, A. I.
    Drosos, A. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : A19 - A20
  • [47] ANTI-TUMOUR NECROSIS FACTOR THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS DOES NOT ATTENUATE CUTANEOUS TUMOUR NECROSIS FACTOR ACTIVITY FOLLOWING A TUBERCULIN SKIN TEST
    Byng-Maddick, Rachel
    Haas, Carolin
    Ehrenstein, Michael
    Noursadeghi, Mahdad
    RHEUMATOLOGY, 2016, 55 : 146 - 146
  • [48] Anti-Tumor Necrosis Factor-Alpha Therapy and Periodontal Parameters in Patients With Rheumatoid Arthritis
    Mayer, Yaniv
    Balbir-Gurman, Alexandra
    Machtei, Eli E.
    JOURNAL OF PERIODONTOLOGY, 2009, 80 (09) : 1414 - 1420
  • [49] Definition of discontinuation of anti-tumour necrosis factor therapy in rheumatoid arthritis: a preliminary proposal
    Braun, J
    Sieper, J
    van der Heijde, D
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (10) : 1023 - 1024
  • [50] IS SERUM AMYLOID A PROTEIN AN USEFUL BIOMARKER TO MONITOR TREATMENT WITH ANTI-TUMOUR NECROSIS FACTOR-ALPHA AGENTS IN SPONDYLOARTHRITIS PATIENTS?
    Aguiar, F.
    Rosa-Goncalves, D.
    Martins-Rocha, T.
    Ferreira, R. M.
    Bernardo, A.
    Brito, I.
    Bernardes, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 468 - 469
12345